A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass
- PMID: 12968231
- DOI: 10.1016/s1053-0770(03)00148-4
A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass
Abstract
Objective: To determine whether there is a difference between on-pump cardiopulmonary bypass (CABG) and off-pump coronary artery bypass grafting (OPCAB) without heparin reversal with regard to bleeding, transfusion requirements, and incidence of surgical re-exploration of the mediastinum.
Design: Retrospective chart review.
Setting: A large academic medical center.
Participants: Two hundred adult patients undergoing cardiac surgery.
Interventions: None.
Measurements and main results: One hundred CABG patients were compared with 100 OPCAB patients. Statistical significance was measured with P values of <or=0.05. The heparin was not reversed in the OPCAB patients. CABG patients received more intraoperative allogeneic red blood cells (median 250 mL v 0 mL, p = 0.002), intraoperative autotransfusion (IAT) (550 mL v 425 mL, p = 0.001), platelets (9% v 1%, p = 0.009), and less albumin (0 mL v 250 mL, p = 0.001) than OPCAB patients. Postoperatively, CABG patients were more likely to receive fresh-frozen plasma (19% v 8%, p = 0.03) and less likely to receive IAT than the OPCAB group. During the initial 4-hour postoperative period, OPCAB patients exhibited greater blood loss via chest tube (290 mL v 385 mL, p = 0.003); however, at 12 hours and 24 hours postoperatively, there was no statistical difference in blood loss between the 2 groups. There were no statistically significant differences in surgical re-exploration of the mediastinum between the CABG and OPCAB groups.
Conclusion: Despite not reversing the heparin at the end of the OPCAB surgery, OPCAB surgery was associated with an overall reduction in allogeneic transfusion requirements.
Comment in
-
OPCAB: heparin reversal?J Cardiothorac Vasc Anesth. 2004 Jun;18(3):394-5, author reply 395. doi: 10.1053/j.jvca.2004.03.025. J Cardiothorac Vasc Anesth. 2004. PMID: 15232827 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
